Puma Biotechnology Investor Relations Material
Latest events
Q4 2023
Puma Biotechnology
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Puma Biotechnology Inc
Access all reports
Puma Biotechnology, Inc. is a biopharmaceutical company focused on the development and commercialization of products to enhance cancer care in the United States and internationally. The company is focused on late-stage development of tarextumab tetraxetan for the treatment of certain advanced cancers, as well as development and commercialization of bevasiranib phosphate for the treatment of gastrointestinal stromal tumors (GIST).
Key slides for Puma Biotechnology Inc
Q2 2023
Puma Biotechnology Inc
Q4 2023
Puma Biotechnology Inc
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States